Trials / Completed
CompletedNCT02470429
Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION
Evaluation of Clinical Outcomes Following the Use of SYSTANE® HYDRATION in Subjects With Dry Eye
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 114 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare SYSTANE® HYDRATION to Hyabak 0.15% based on total ocular surface staining scores (TOSS) at Day 42.
Detailed description
Subjects will first be dispensed preservative-free 0.9% saline eye drops (saline eye drops) to be used during the Run-in phase between Screening Visit and Day 0 (Visit 1). Subjects who qualify will be randomized in a 1:1 manner to receive either treatment with SYSTANE® HYDRATION Lubricant Eye Drops or Hyabak 0.15% Eye Drops.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SYSTANE HYDRATION lubricant eye drops | Preserved with POLYQUAD (polidronium chloride) 0.001% |
| DEVICE | Hyabak 0.15% eye drops | Preservative-free |
| DRUG | 0.9% saline eye drops | Preservative-free, one drop 4 times a day in each eye (run-in period) |
Timeline
- Start date
- 2015-07-17
- Primary completion
- 2016-05-26
- Completion
- 2016-05-26
- First posted
- 2015-06-12
- Last updated
- 2018-07-02
- Results posted
- 2017-06-16
Source: ClinicalTrials.gov record NCT02470429. Inclusion in this directory is not an endorsement.